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Background. Health professionals, including general practitioners involved in followup of breast cancer patients, need to
systematically assess opportunities to oﬀer patients support with ongoing or new problems. Methods. A self-administered needs
assessment questionnaire was developed with reference to a multidisciplinary team. Short, evidence-based, readable questions
were emphasized, and questions were tested for face validity. The questions ﬂowed across three domains: physical, social, and
psychological.Content validity anduser friendliness were assessed. Results. A ﬁnalset of 30 questions wasrated as easy to read and
comprehend(Flesch Reading Easescore65.8andFlesch-Kincaid Grade Level 6.9).Whenpiloted with twenty-one patients theself-
administeredquestionnairedetected 121itemsofunmetneed encompassingallthree domains.Conclusions.Thisself-administered
questionnaire has the potential to assistin the holistic assessmentof breast cancer patient after treatment. The clinical value of the
self-administered questionnaire will need to be further tested before it can be widely adopted.
1.Introduction
Most women who are diagnosed with breast cancer will
survive ﬁve or more years after diagnosis, and in many
countries breast cancer patients attend follow-up clinics for
several years following treatment [1]. The value of follow-up
care is based on proactive screening for conditions that are
amenable to intervention in order to maximize the prospects
for survival and high quality of life. Most investigations
carried out or treatment oﬀered to patients is guided by
the symptoms or problems reported to practitioners. A
recent study reported that most patients did not volunteer
their symptoms or problems following breast cancer to their
general practitioner, despite consulting that practitioner,
but did report signiﬁcant problems to their breast care
nurse when systematically questioned [2]. This paper is
a ﬁrst step in developing a tool which may be of value in
clinicalpractice.Healthprofessionalsmaybeneﬁtfromaself-
administered questionnaire to assist with consulting patients
about whether further treatment is indicated [3]. To our
knowledge such a self-administered questionnaire has not
been published.
As an overall focus for the self-administered question-
naire the team adopted theories which purport that a breast
cancer diagnosis is an “extraordinary” life event which
brings about a shift in identity for women [4]. Therefore,
we incorporated theories on embodiment from medical
sociology by including questions on changes in physical
appearance and functioning, relationships, interests, and
overall well-being [5]. This incorporates the concept of
biographical disruption [6–8], biographical reinforcement
[9],andbiographicalreinvention[10].Thesetheoriespredict2 International Journal of Family Medicine
that the woman is likely to experience a shift in perspective
following the diagnosis and treatment, and therefore, one
mightanticipatethatsomepeoplewithbreastcancerstruggle
toadjustafterwhatmayhavebeenatraumaticlifeevent[11].
Patients often do not volunteer problems unless prompted,
perhaps because they are unaware that eﬀective treatment
or support is available or they consider that long-term dys-
function is an inevitable outcomeof breast cancer treatment.
We aim to devise a self-administered questionnaire to help
proactively screen patients for physical, psychological, and
social dysfunction following treatment for breast cancer.
2.Methodology
A team of relevant health care professionals was assembled
including members of the following specialties, numbers in
bracketsrefer to number of representatives:
(i) general practice (1),
(ii) dietetics (2),
(iii) nursing (1),
(iv) occupational therapy (2),
(v) physiotherapy (1),
(vi) psychology (1),
(vii) sexology (2).
The self-administered questionnaire builds on a pre-existing
interview self-administered questionnaire developed locally.
Each member of the team proposed a series of questions
that might detect ongoing or new problems for the patient.
The team was asked to identify the evidence as the basis
for the questions. There was an emphasis on short, readable
questions. The team was assembled at a workshop to review
the proposed questionnaire. The questions were examined
for face validity and tested for readability. The survey and
rationale for the questions were shared in the team in round
robin fashion until there was consensus on the ﬁnal ver-
sion of the self-administered questionnaire. Implementation
theory suggests that factors to be taken into account in
the planning of a new tool should include its potential
compatibility with existing routines [12]. In other words
the tool should be practical and readily assimilated into the
routines of clinical practice. The tool was therefore piloted
with 21 breast cancer patients attending a hospital clinic
1–4 years after treatment to test for content validity. The
pilot testing was also aimed at testing the user friendliness
and to assess if the self-administered questionnaire helped to
screen for possible problems for each patient in any of the
domains. Responses to the self-administered questionnaire
were reviewed by the team and recommendations made for
interventions based on individual responses. The predictive
validityoftheself-administered questionnaire will befurther
tested in a follow-up study in which patients will be
oﬀered interventions with reference to the self-administered
questionnaire.
New
new
new
new
new
most of the time?
most 
of the time
Do you feel that your diagnosis and treatment
Name: DOB:
Address: Name of GP:
Please think of the last 6–12 months when you answer the following questions:
Date:
Yes No Comments
(1) A e in the appearance of either breast
since your treatment
(2) A lump or thickening in either breast
(3) Leakage or bleeding from either nipple, or a
rash or change in the appearance of either nipple
(4) A lump under the arm or in the neck
(5) Any unexplained weight loss, that is, not caused
by deliberate dieting
(6) A cough, shortness of breath, or chest pain
(7) Abdominal pain, a change in your bowel habit
swelling of the abdomen
Additional comments:
(8) A persistent pain in any part of your body,
that is, muscle or joint pain
(9) Do you have any pain in the neck or between
the shoulder blades?
(10) Has your weight been stable?
(11) Are you happy with your current weight?
(12) unexplained tiredness or general loss
of well being
(13) Are you using any complementary medicine?
or are you on a special diet?
(14) Do you have any swelling of the arm on the
side of your breast cancer treatment?
(15) Do you experience any tightness or aching
in your arm?
(16) Do you have any tight bands like “cords” or
“strings” under your arm or in your arm pit, or in
the soft tissue at the elbow or wrist?
(17) Problems with shoulder mobility on the side
of your surgery
(18) Are you satisﬁed with your level of
involvement in social activities and interests?
If not, why?
(19) How many standard alcoholic drinks did you
have per week in the last month? [e.g. of standard
drinks = 475mL light beer, 285mL regular beer,
100mL table wine, 60mL fortiﬁed wine 30mL
spirit/liqueur)
(20) Are you doing the recreational/sporting! exercis
activities you participated in prior to your
surgery? If not, why?
(21) Are you getting at least 30min moderate physical
activity at least 5 times/week?
(22) Difficulty sleeping which is not your usual pattern
(23) Hot ﬂushes which are causing you difficulty
(24) Any urinary leakage? If yes:
(a) Does it happen when you are coughing,
sneezing, laughing, or lifting heavy items?
(b) Does the loss occur in connection with sudden
urge to pass urine?
(25)
had impacted on your relationships?
(26) Do you feel you are having trouble coping
with everyday life
(28) Do you feel anxious or worried most of the time?
(29) (a) Have you noticed any change in your sexual
interest and desire?
(b) Have you experienced any change in sensation?
For example touch, enjoyment of sensation
(c) Orany change in sexual functioning, for example,
vaginal dryness, pain with penetration?
(30) Consider all the ways in which illness and health conditions may affect you at this time, please make
a mark below to show how you are doing:
Very poorly Very well
(27) Do you feel depressed, hopeless, or “ﬂat”
The following questions will assist the multidisciplinary team to design a follow-up care plan. Some of the
symptoms referred to in the questionnaire may be due to common ailments and may not be cause for
concern. Sometimes breast cancer treatment can exacerbate menopausal or hormone deﬁciency symptoms.
The following symptoms may be related and are often mild and resolve with time; but if they signiﬁcantly
affect your daily life please mention. If you have noticed anything NEW, it is important to mention this.
Patient details
e in the appearance of either breast
chang
Figure 1: CCC (Cancer Care Coordinator) project—follow-up
assessment.International Journal of Family Medicine 3
Table 1: Justiﬁcation for questions chosen per specialty.
Speciality Questions Rationale
Medicine 1–8, 23, 27, 28 Symptoms of recurrent breast cancer [13], depression [14], menopausal
symptoms [15, 16], joint pain related to treatment [17]
Physiotherapy 9, 14–17, 24, 29 Shoulder pain [18], lymphoedema [18]
OT 18, 20 Adjustment and occupational issues [19]
Psychology 5, 19, 22, 25, 26, 27, 28
Depression, anxiety and general psychological well-being [20, 21], urinary
incontinence [22–25], alcohol abuse as a risk factor for recurrence [21],
undetected psychological distress [26]
Sexology 25, 29 Common sexual diﬃculties experienced following cancer treatment [27, 28]
Dietetics 5, 10, 11, 13, 20 Obesity as a risk of recurrence [29], motivation to maintain a healthy weight,
physical activity as protection against recurrence [30]
Table 2: Problems identiﬁed on application of the self-administered questionnaire.
Domain Type of problem Number of patients/21
Physical
Upper body/arm dysfunction 14
Weight management 9
Urinary symptoms/incontinence 12
Lower bowel symptoms 1
Menopause symptoms 16
Other physical symptoms 6
Sleep disturbance 13
Psychological
Body image concerns 8
Depression 6
Other psychological distress 8
Psychosexual problems 16
Social Employment issues 5
Financial concerns 7
3.Results
For each dimension the following speciﬁc clinical evidence
was incorporated into the questions by each member of
the multidisciplinary team. The sequence of questions was
reassigned to ensure a logical ﬂow across the domains of
interest (see Figure 1). The Flesch Reading Ease score [31]
was 65.8, and the Flesh-Kincaid Grade Level was 6.9 [32].
The speciﬁc justiﬁcation for the questions per specialty
is recorded in Table 1. A key function in followup is to
rule out recurrence of cancer and to assess for side eﬀects
of adjuvant therapy including tiredness, musculoskeletal
complaints, weight gain, sexual dysfunction, gynaecologic
symptoms, vasomotor symptoms, and urinary incontinence
[33]. Urinary incontinence is a condition that can be treated
eﬀectively [22, 23], and yet care-seeking is low [24]. Barriers
to care-seeking include embarrassment, the perception that
symptoms are a normal part of aging, lack of awareness
that eﬀective treatments are available, and believing the
symptoms do not warrant medical attention [25]. Therefore,
theself-administered questionnaire includesdirect questions
that may initiate a conversation about symptoms that can
be followed by appropriate treatment. The self-administered
questionnairewasappliedto21patients,andaseriesofissues
(see Table 2) were identiﬁed.
4.Discussion
The self-administered questionnaire encompassed the phys-
ical, psychological, and social domains and is divided into
categories.
4.1. Physical
(1) Symptoms of breast cancer recurrence.
(2) Physical sequelae of treatment.
(3) Nutritional eﬀects of treatment.
(4) Prevention of recurrence.
4.2. Psychological
(1) Psychological sequelae of diagnosis and treatment.
(2) Symptoms of major depressive illness.
4.3. Social
(1) Relationship problems consequent to diagnosis and
treatment.
(2) Sexual dysfunction.4 International Journal of Family Medicine
Questions were designed to encourage proactive exploration
of issues that may impact on the health and well-being of
the patient. The Flesch reading ease test rates text on a 100-
point scale [31] .T h eh i g h e rt h es c o r ei s ,t h ee a s i e ri ti s
to understand the document. For most standard ﬁles, the
designers recommend a score between 60 and 70. Similarly,
Flesh-Kincaid Grade test rates text on a US school grade
level [32]. For example, a score of 8.0 means that an eighth
grader, an early high school student, can understand the
document [32] .I tc a na l s om e a nt h en u m b e ro fy e a r so f
education generally required to understand this text. For
most documents, the aim is for a score of approximately
7.0 to 8.0. Therefore, the self-administered questionnairewas
rated as easy to read and comprehend.
A key task in followup is to take the opportunity to
assessforrecurrentcancer.Alongsidetheplethoraofphysical
symptoms and side eﬀects, cancer can also result in a wide
range of psychological and emotional problems which may
contribute to greater patient distress [26]. The prevalence
ratesofdistress inbreastcancerpatientsarewelldocumented
andrangefrom35to49%intheUSAandEurope[34].There
are few if any published self-administered questionnaires
that can be used to help assess patients’ needs following
specialist treatment for chronic and complex conditions.
Suchself-completedself-administered questionnairesshould
be followed up with an interview and if necessary physical
examination by a health practitioner with the necessary skill
set.
The self-administered questionnaire detected symptoms
or problems related to each domain and 121 individual
items of unmet need despite the fact that the patients
were already attending a hospital clinic and had access to
their general practitioner. This emphasised the value of a
proactive approach to the assessment of patients in the
period following the treatment of breast cancer.
5.Conclusion
This self-administered screening tool may assist in identify-
ing physical psychological and social dysfunction distress in
women after breast cancer treatment. It contains screening
questions focusing on psychological issues which may con-
tribute to distress, including depression, anxiety, and general
coping. The information collected from this screening tool,
and elaborated on in the clinical interview with health
professionals, should assist in identifying patients who are
experiencingpsychologicaldistressand assist practitionersin
recommending appropriate follow-up care plans. However
theself-administered questionnaireneedstobefurthertested
to conﬁrm that it has predictive and concurrent validity.
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